Incidence of gastro‐intestinal anomalies and surgical outcome of fetuses diagnosed with echogenic bowel and bowel dilatation

Background We aimed to evaluate the incidence of gastro‐intestinal (GI) anomalies and surgical outcome in fetuses diagnosed with either echogenic bowel (EB) or EB plus bowel dilatation (BD) but no associated chromosomal, DNA and/or additional structural defects. Methods A 10‐year (2008‐2018) retrospective review was performed on all fetuses diagnosed with EB and EB+BD (RES‐18‐0000‐072Q). Results are reported as number of cases (%) and mean ±SD. Fisher's exact test, Mann‐Whitney U test and logistic regression were used to identify differences between groups and predisposing factors for gastro‐intestinal anomalies. Results We identified 41 fetuses with EB and 14 fetuses with EB+BD. Post‐natal surgical intervention was required in no patient of the EB group and in 7/14 (50%) of the EB+BD group, p